<DOC>
	<DOCNO>NCT00049946</DOCNO>
	<brief_summary>A Placebo Controlled Study For Patients With Schizophrenia</brief_summary>
	<brief_title>Schizophrenia Study In Adults</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Patient must meet diagnostic criterion schizophrenia . Patients psychotic disorder . Patients whose condition due direct physiological effect substance ( e.g. , drug abuse ) general medical condition . Patients history autistic disorder another pervasive developmental disorder . Patients epilepsy history seizure require treatment . Patients exclude take drug risperidone . Patients pose current serious suicidal homicidal risk . Patients adequately stabilized treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Talnetant</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>NK3 receptor antagonist</keyword>
	<keyword>psychosis</keyword>
</DOC>